Related Experiment Videos
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging
Martina Sollini1,2,3, Rodolfo Hurle2, Marcello Rodari3
1Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy.
European Journal of Nuclear Medicine and Molecular Imaging
|March 22, 2022
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Beyond TNM: Tumor Volume as a Prognostic Marker in Laryngeal Cancer.
The Laryngoscope·2026
PD-L1 PET/CT imaging with 18F-BMS-986,229 and 18F-BMS-986,192 in patients with advanced-stage non-small cell lung cancer.
European journal of nuclear medicine and molecular imaging·2026
A FABulous approach to image human macrophages.
European journal of nuclear medicine and molecular imaging·2026
Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.
European journal of nuclear medicine and molecular imaging·2026
Cardiac sympathetic nerve activity in the non-culprit lesion predicts poor prognosis in patients with STEMI.
European journal of nuclear medicine and molecular imaging·2026
The prognostic value of quantitative myocardial blood flow and flow reserve by dynamic CZT-SPECT for major adverse cardiovascular events.
European journal of nuclear medicine and molecular imaging·2026
Colonic metastasis from anaplastic thyroid carcinoma: The value of [18F]FDG PET/CT in an unusual presentation.
European journal of nuclear medicine and molecular imaging·2026
Marker-assisted backcross breeding to develop wheat lines with stable yellow rust resistance without yield penalties.
Frontiers in plant science·2026